Peroxisomal ABC transporters: an update

A Tawbeh, C Gondcaille, D Trompier… - International Journal of …, 2021 - mdpi.com
ATP-binding cassette (ABC) transporters constitute one of the largest superfamilies of
conserved proteins from bacteria to mammals. In humans, three members of this family are …

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

BAC Cree, G Cutter, JS Wolinsky… - The Lancet …, 2020 - thelancet.com
Background There is an unmet need to develop therapeutic interventions directed at the
neurodegeneration that underlies progression in multiple sclerosis. High-dose …

High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials

AI Espiritu, PPM Remalante-Rayco - Multiple Sclerosis and Related …, 2021 - Elsevier
Background Biotin may activate the acetyl-CoA-, 3-methylcrotonyl-CoA-, propionyl-CoA-,
and pyruvate carboxylases to increase myelin repair and/or synthesis, and may enhance the …

ABCD1 transporter deficiency results in altered cholesterol homeostasis

A Buda, S Forss-Petter, R Hua, Y Jaspers, M Lassnig… - Biomolecules, 2023 - mdpi.com
X-linked adrenoleukodystrophy (X-ALD), the most common peroxisomal disorder, is caused
by mutations in the peroxisomal transporter ABCD1, resulting in the accumulation of very …

Pharmacotechnical, Physico-Chemical, and Antioxidant Evaluation of Newly Developed Capsule Formulations

EA Ozon, IDM Iuga, M Mititelu, AM Musuc… - International Journal of …, 2023 - mdpi.com
The excess of free radicals causes numerous imbalances in the body that lead to premature
aging, the degradation of internal structures, and the appearance of numerous pathologies …

Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

J Parameswaran, L Goicoechea, L Planas-Serra… - Acta …, 2022 - Springer
Aberrant endocannabinoid signaling accompanies several neurodegenerative disorders,
including multiple sclerosis. Here, we report altered endocannabinoid signaling in X-linked …

[HTML][HTML] Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies

CY Ma, C Li, X Zhou, Z Zhang, H Jiang, H Liu… - Biomedicine & …, 2021 - Elsevier
Abstract X-linked adrenoleukodystrophy (X-ALD) is an inherited neurodegenerative disorder
associated with mutations of the ABCD1 gene that encodes a peroxisomal transmembrane …

Modulation of mitochondrial and inflammatory homeostasis through RIP140 is neuroprotective in an adrenoleukodystrophy mouse model

P Ranea‐Robles, J Galino, L Espinosa… - Neuropathology and …, 2022 - Wiley Online Library
Aims Mitochondrial dysfunction and inflammation are at the core of axonal degeneration in
several multifactorial neurodegenerative diseases, including multiple sclerosis, Alzheimer's …

[HTML][HTML] Molecular Mechanisms of Biotin in Modulating Inflammatory Diseases

M Sakurai-Yageta, Y Suzuki - Nutrients, 2024 - mdpi.com
Biotin, also known as vitamin B7 or vitamin H, is a water-soluble B-complex vitamin and
serves as an essential co-enzyme for five specific carboxylases. Holocarboxylase synthase …

The role of oxidative stress and inflammation in X-link adrenoleukodystrophy

J Yu, T Chen, X Guo, MI Zafar, H Li, Z Wang… - Frontiers in …, 2022 - frontiersin.org
X-linked adrenoleukodystrophy (X-ALD) is an inherited disease caused by a mutation in the
ABCD1 gene encoding a peroxisomal transmembrane protein. It is characterized by the …